Fast Five Quiz: Waldenström Macroglobulinemia Workup

Emmanuel C. Besa, MD


February 01, 2021

IgM protein levels are predictive of outcomes in WM, entering into the staging system when the IgM level exceeds 7000 mg/dL. Age, hemoglobin level, platelet count, beta-2 microglobulin, and monoclonal IgM concentrations are also important prognostically.

Lactate dehydrogenase is not considered in the International Prognostic Scoring System for WM.

While the immunoglobulin free light chain assay has proven its clinical utility in myeloma, its value is not well established in WM.

CXCR4 mutations are found in approximately 30% of patients with WM, but genetic testing for this mutation is not used in staging; it is only recommended when considering treatment with the Bruton tyrosine kinase (BTK) inhibitors, such as ibrutinib.

Learn more about staging and risk assessment in WM.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.